Additionally, LYPLA1 was found to be highly expressed in malignant cervical cancer tissues, where it was associated with the upregulation of EMT-inducing TIAM1 and GREM1 and a decrease in mesenchymal markers [16, 17]. The gene discussed is GREM1; the disease is cervical carcinoma.